{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:21:12Z","timestamp":1788459672061,"version":"build-2803163510"},"reference-count":40,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,7,31]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>mDia1 deficiency led to a cell-autonomous overexpression of CD14 on granulocytes and a hypersensitive innate immune response. mDia1 heterozygous and knockout mice developed age-dependent MDS that was accelerated by chronic stimulation of the innate immunity.<\/jats:p>","DOI":"10.1182\/blood-2014-01-552463","type":"journal-article","created":{"date-parts":[[2014,6,3]],"date-time":"2014-06-03T06:46:21Z","timestamp":1401777981000},"page":"780-790","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":52,"title":["Aberrant overexpression of CD14 on granulocytes sensitizes the innate immune response in mDia1 heterozygous del(5q) MDS"],"prefix":"10.1182","volume":"124","author":[{"given":"Ganesan","family":"Keerthivasan","sequence":"first","affiliation":[{"name":"Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baobing","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematopathology and Laboratory Medicine and Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad E.","family":"Harris","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Harvard Stem Cell Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juehua","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley A.","family":"Basiorka","sequence":"additional","affiliation":[{"name":"Department of Hematopathology and Laboratory Medicine and Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Schipma","sequence":"additional","affiliation":[{"name":"Center for Genetic Medicine, Northwestern University, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McElherne","sequence":"additional","affiliation":[{"name":"Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K.","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pellagatti","sequence":"additional","affiliation":[{"name":"Nuffield Division of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Boultwood","sequence":"additional","affiliation":[{"name":"Nuffield Division of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan F.","family":"List","sequence":"additional","affiliation":[{"name":"Department of Hematopathology and Laboratory Medicine and Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Williams","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Harvard Stem Cell Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2019111613115158800_B1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.seminhematol.2012.07.002","article-title":"Overview of myelodysplastic syndromes.","volume":"49","author":"Beris","year":"2012","journal-title":"Semin Hematol"},{"issue":"5","key":"2019111613115158800_B2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1053\/j.seminoncol.2011.04.007","article-title":"Classification and prognostic evaluation of myelodysplastic syndromes.","volume":"38","author":"Cazzola","year":"2011","journal-title":"Semin Oncol"},{"key":"2019111613115158800_B3","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow"},{"issue":"19","key":"2019111613115158800_B4","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2019111613115158800_B5","first-page":"1003","article-title":"Chromosome abnormalities in the myelodysplastic syndromes.","volume":"15","author":"Heim","year":"1986","journal-title":"Clin Haematol"},{"issue":"7","key":"2019111613115158800_B6","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/leu.2009.53","article-title":"Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer.","volume":"23","author":"Ebert","year":"2009","journal-title":"Leukemia"},{"issue":"7176","key":"2019111613115158800_B7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature06494","article-title":"Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.","volume":"451","author":"Ebert","year":"2008","journal-title":"Nature"},{"issue":"1","key":"2019111613115158800_B8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nm.2063","article-title":"A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome.","volume":"16","author":"Barlow","year":"2010","journal-title":"Nat Med"},{"issue":"2","key":"2019111613115158800_B9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood-2007-01-068809","article-title":"Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders.","volume":"110","author":"Joslin","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2019111613115158800_B10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nm1512","article-title":"Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.","volume":"13","author":"Liu","year":"2007","journal-title":"Nat Med"},{"issue":"2","key":"2019111613115158800_B11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2013-05-506568","article-title":"Cell intrinsic and extrinsic factors synergize in mice with haploinsufficiency for Tp53, and two human del(5q) genes, Egr1 and Apc.","volume":"123","author":"Stoddart","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2019111613115158800_B12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nm.2054","article-title":"Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.","volume":"16","author":"Starczynowski","year":"2010","journal-title":"Nat Med"},{"issue":"17","key":"2019111613115158800_B13","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1182\/blood-2010-12-324715","article-title":"Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome.","volume":"118","author":"Kumar","year":"2011","journal-title":"Blood"},{"issue":"39","key":"2019111613115158800_B14","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1038\/onc.2009.207","article-title":"5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.","volume":"28","author":"Eisenmann","year":"2009","journal-title":"Oncogene"},{"issue":"6","key":"2019111613115158800_B15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.devcel.2006.05.001","article-title":"Staying in shape with formins.","volume":"10","author":"Faix","year":"2006","journal-title":"Dev Cell"},{"issue":"6","key":"2019111613115158800_B16","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.4049\/jimmunol.0803838","article-title":"The mDial formin is required for neutrophil polarization, migration, and activation of the LARG\/RhoA\/ROCK signaling axis during chemotaxis.","volume":"182","author":"Shi","year":"2009","journal-title":"J Immunol"},{"issue":"9","key":"2019111613115158800_B17","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1084\/jem.20062647","article-title":"Impaired T lymphocyte trafficking in mice deficient in an actin-nucleating protein, mDia1.","volume":"204","author":"Sakata","year":"2007","journal-title":"J Exp Med"},{"issue":"26","key":"2019111613115158800_B18","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1182\/blood-2010-01-264150","article-title":"Rho-mDia1 pathway is required for adhesion, migration, and T-cell stimulation in dendritic cells.","volume":"116","author":"Tanizaki","year":"2010","journal-title":"Blood"},{"issue":"16","key":"2019111613115158800_B19","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1158\/0008-5472.CAN-07-1467","article-title":"Myeloproliferative defects following targeting of the Drf1 gene encoding the mammalian diaphanous related formin mDia1.","volume":"67","author":"Peng","year":"2007","journal-title":"Cancer Res"},{"issue":"8","key":"2019111613115158800_B20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3324\/haematol.2009.007682","article-title":"Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.","volume":"94","author":"Cazzola","year":"2009","journal-title":"Haematologica"},{"issue":"12","key":"2019111613115158800_B21","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.4049\/jimmunol.150.12.5556","article-title":"Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide.","volume":"150","author":"Haziot","year":"1993","journal-title":"J Immunol"},{"issue":"12","key":"2019111613115158800_B22","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1073\/pnas.0306906101","article-title":"Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations.","volume":"101","author":"Gioannini","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"2019111613115158800_B23","doi-asserted-by":"crossref","first-page":"21129","DOI":"10.1074\/jbc.M009164200","article-title":"Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2.","volume":"276","author":"da Silva Correia","year":"2001","journal-title":"J Biol Chem"},{"issue":"2","key":"2019111613115158800_B24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.hoc.2010.02.008","article-title":"Innate immune signaling in the myelodysplastic syndromes.","volume":"24","author":"Starczynowski","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"issue":"9","key":"2019111613115158800_B25","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.4049\/jimmunol.1003438","article-title":"Chronic exposure to a TLR ligand injures hematopoietic stem cells.","volume":"186","author":"Esplin","year":"2011","journal-title":"J Immunol"},{"issue":"1","key":"2019111613115158800_B26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0037-1963(00)90026-X","article-title":"Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia.","volume":"37","author":"Young","year":"2000","journal-title":"Semin Hematol"},{"issue":"8","key":"2019111613115158800_B27","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.4049\/jimmunol.178.8.5277","article-title":"Inflammatory reactive oxygen species-mediated hemopoietic suppression in Fancc-deficient mice.","volume":"178","author":"Sejas","year":"2007","journal-title":"J Immunol"},{"issue":"1","key":"2019111613115158800_B28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-013-1863-5","article-title":"Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes.","volume":"93","author":"Giagounidis","year":"2014","journal-title":"Ann Hematol"},{"issue":"14","key":"2019111613115158800_B29","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJMoa061292","article-title":"Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.","volume":"355","author":"List","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111613115158800_B30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa041668","article-title":"Efficacy of lenalidomide in myelodysplastic syndromes.","volume":"352","author":"List","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111613115158800_B31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.163.1.380","article-title":"Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.","volume":"163","author":"Corral","year":"1999","journal-title":"J Immunol"},{"issue":"8","key":"2019111613115158800_B32","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3324\/haematol.2012.064642","article-title":"Impaired clearance of apoptotic cells leads to HMGB1 release in the bone marrow of patients with myelodysplastic syndromes and induces TLR4-mediated cytokine production.","volume":"98","author":"Velegraki","year":"2013","journal-title":"Haematologica"},{"issue":"2","key":"2019111613115158800_B33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/shem.2002.31911","article-title":"Neutropenia: causes and consequences.","volume":"39","author":"Boxer","year":"2002","journal-title":"Semin Hematol"},{"issue":"1","key":"2019111613115158800_B34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2141.1998.00933.x","article-title":"A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome.","volume":"103","author":"Gersuk","year":"1998","journal-title":"Br J Haematol"},{"issue":"10","key":"2019111613115158800_B35","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood.V98.10.3058","article-title":"Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis.","volume":"98","author":"Zang","year":"2001","journal-title":"Blood"},{"key":"2019111613115158800_B36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition.","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"2019111613115158800_B37","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0952-7915(02)00343-6","article-title":"Control of adaptive immune responses by Toll-like receptors.","volume":"14","author":"Barton","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"2019111613115158800_B38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-pathol-011811-132436","article-title":"Molecular pathophysiology of myelodysplastic syndromes.","volume":"8","author":"Lindsley","year":"2013","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"2019111613115158800_B39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/gast.2002.34161","article-title":"Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-\u03b1 production.","volume":"123","author":"Enomoto","year":"2002","journal-title":"Gastroenterology"},{"issue":"25","key":"2019111613115158800_B40","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1182\/blood-2008-09-038935","article-title":"How I treat patients with myelodysplastic syndromes.","volume":"113","author":"Stone","year":"2009","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/124\/5\/780\/541689\/780.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/124\/5\/780\/541689\/780.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T22:15:43Z","timestamp":1689286543000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/124\/5\/780\/116632\/Aberrant-overexpression-of-CD14-on-granulocytes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,31]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,7,31]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2014-01-552463","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,31]]}}}